May 28, 2026

LUMC Biobank adapted protocol for plasma isolation from whole blood, based on the national Dutch standard

 Forked from National Biobank standard protocol for plasma isolation from whole blood in Dutch University Medical Centers
This  protocol  is a draft, published without a DOI.
  • Yvonne D. Krom1,2,
  • Jessica C. de Greef3,
  • Ellis Niemantsverdriet4,
  • Roger R. Snijder4
  • 1Department of Neurology, Leiden University Medical Center, Leiden, the Netherlands;
  • 2Duchenne Center Netherlands;
  • 3Department of Human Genetics, Leiden University Medical Center, Leiden, the Netherlands;
  • 4LUMC Biobank Organization, Leiden University Medical Center, Leiden, The Netherlands
Yvonne D. Krom
Icon indicating open access to content
QR code linking to this content
External link: https://openbioresources.metajnl.com/articles/10.5334/ojb.23
Protocol Citation: Yvonne D. Krom, Jessica C. de Greef, Ellis Niemantsverdriet, Roger R. Snijder 2026. LUMC Biobank adapted protocol for plasma isolation from whole blood, based on the national Dutch standard. protocols.io https://dx.doi.org/
Manuscript citation:
Manniën, J., Ledderhof, T., Verspaget, H.W., Snijder, R.R., Flikkenschild, E.F., van Scherrenburg, N.P.C., Stolk, R.P. and Zielhuis, G.A. 2017 The Parelsnoer Institute: A National Network of Standardized Clinical Biobanks in the Netherlands. Open Journal of Bioresources 4: 3,  DOI: https://doi.org/10.5334/ojb.23
License: This is an open access  protocol  distributed under the terms of the  Creative Commons Attribution License,  which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited
Protocol status: Working
We use this protocol and it's working
Created: May 28, 2026
Last Modified: May 28, 2026
Protocol  Integer ID: 318110
Keywords: plasma from whole blood, processing plasma, processing of plasma, whole blood sample, plasma, whole blood, processing, blood, standard operating protocol, protocol, biobank of Dutch academic centers, Dutch academic centers, biobank, national biobank standard protocol for plasma isolation, lumc biobank facility, biobank of all dutch academic center, biobank regulation, local biobank, clinical data, whole blood in dutch university medical center, national biobank, tissue sample, biobank information management system, store biomaterial, dutch university medical center, plasma from whole blood, plasma isolation, biomarker analysis, lumc it department under supervision, downstream data use, technology improvements in sample processing, potential impact on biomarker analysis, blood derivate, lumc it department, national standard, accordance with gdpr, lumc, standard protocol, gdpr, human body material, dna, isolating plasma, data, dutch academic center, donor without access, lumc biobank, protocol for plasma isolation, nation
Abstract
As of 2007, the 8 Dutch University Medical Centers (UMCs) have agreed to collaborate in, and exchange knowledge regarding, setting up local biobanks, where materials for a wide variety of diseases were collected under the same protocol. These nation-wide protocols are, to a large extent, still in place for most materials collected in the extant 7 UMC biobanks. Materials collected comprise blood derivates, DNA, urine, and tissue samples.
All materials and data are handled in accordance with GDPR (AVG) and Biobank regulations. Researchers may request human body material and/or clinical data.
At LUMC, the protocols to collect and store biomaterials according to national standards have been refined over the years, for example, through technology improvements in sample processing. Registration and storage of all materials is carried out in the Biobank information management system, Sample Navigator. All materials intended for scientific research are assigned a unique code that cannot be traced to the donor without access to Sample Navigator. Access is strictly governed by LUMC IT department under supervision of LUMC Biobank Facility.
All pre‑analytical deviations are systematically documented at the sample level to ensure transparency, reproducibility, and high‑quality downstream data use. Deviations are recorded using predefined categories, each accompanied by structured metadata and optional free‑text clarification. This enables traceability, supports FAIR data principles, and allows researchers to assess potential impact on biomarker analyses or clinical interpretation.
This protocol outlines the procedure for isolating plasma from whole blood at the LUMC, implemented since 2023 and adapted from the national Dutch standard protocol. The primary modification is the homogenization of samples.
Materials
  • K2E (EDTA) tube
  • Centrifuge Hettich Rotina 380R or Centrifuge Hettich Rotina 460RS
  • Various adjustable calibrated pipettes
  • Corning pipette tips with filter, sterile, 100 - 1000 µl
  • Capped mixing tube
  • Micronics/2D barcode tubes
Safety warnings
Treat all blood samples as potentially infectious. No hazardous substances are used.
Ethics statement
Sample collection under this protocol may only be performed with prior approval from the user’s Institutional Ethics Board (or equivalent ethics committee) and only when patients have provided informed consent for the specific biobank.
Procedure
4 ml whole blood is collected in a commercially available anticoagulant-treated K2E (EDTA) tube.
The K2E tube is processed within 4 hours after collection.

Before initiating sample processing (and within 4 hours after collection), the K2E tube is inspected for pre‑analytical deviations. The following deviation categories are captured for the tube, each accompanied by a free‑text field for additional notes:
  • Hemolytic material
  • Lipemic material
  • Icteric material
  • Incorrect tube type used
  • Incorrect storage temperature prior to processing
  • Deviated storage duration prior to processing
The K2E tube is then spun at 2350 RCF for 10 minutes at 20°C to remove cells.
Next, the supernatant is collected in a mixing tube with cap by pipetting without disturbing the red pellet on the bottom of the K2E tube.
After homogenization of the collected plasma by thoroughly mixing, 3 aliquots of plasma (400 µl each) are distributed in Micronics/2D barcode tubes.
The barcode tubes with plasma are then stored overnight at -20°C (or until 5 pm on Fridays), after which the tubes are stored in a UHT freezer at -80°C.

After centrifugation and completion of the storage procedure, additional pre‑analytical deviations related to the processing phase are recorded. The following deviation categories are captured for the sample, each with a free‑text field for additional notes:
  • Deviation during centrifugation
  • Deviation in mixing or homogenization
  • Storage incident
Protocol references
Manniën, J., Ledderhof, T., Verspaget, H.W., Snijder, R.R., Flikkenschild, E.F., van Scherrenburg, N.P.C., Stolk, R.P. and Zielhuis, G.A. 2017 The Parelsnoer Institute: A National Network of Standardized Clinical Biobanks in the Netherlands. Open Journal of Bioresources 4: 3,  DOI: https://doi.org/10.5334/ojb.23